Case reportPublished 29 May 2021
Successful switching to Infliximab after systemic allergic reaction to Adalimumab drug: a case report
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Subjective: To describe a case of systemic allergic reaction to Adalimumab drug in an Ankylosing Spondylitis (AS) patient and switching to Infliximab. Case report: A 43-year-old middleeastern man with a history of AS who was initiated with the treatment of Adalimumab. After the second injection of the drug immediate systemic allergic reaction with the symptoms of dizziness, shortness of the breath, angioedema of the limps and generalized rashes and itching happened. Discussion: Systemic reactions to Adalimumab although rare have been reported before. In case of allergic reaction to this drug desensitization and switching to another anti-TNFα have been successfully tried.
Subjects
RheumatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Clinical Rheumatology
- SubjectRheumatology
- BylineArticles whose byline prints “Alireza Sadeghi”